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Background:  Dengue  is a widely  spread  arboviral  disease  in  tropical  and subtropical  regions  of  the  world.
Dengue  fever  presents  clinical  characteristics  similar  to other  febrile  illness.  Thus laboratory  diagnosis  is
important  for adequate  management  of  the  disease.
Objectives:  The  present  study  was  designed  to evaluate  the  diagnostic  performance  of real-time  PCR and
serological  methods  for  dengue  in a real  epidemic  context.
Study  design:  Clinical  data  and  blood  samples  were  collected  from  consecutive  patients  with  suspected
dengue  who  attended  a  primary  health  care  unit  in  Belo  Horizonte,  Brazil.  Serologic  methods  and  real-
time PCR  were  performed  in serum  samples  to conﬁrm  dengue  diagnosis.
Results:  Among  the  181  consecutive  patients  enrolled  in this  study  with  suspected  dengue,  146  were
considered  positive  by  serological  criteria  (positive  NS1  ELISA  and/or  anti-dengue  IgM  ELISA)  and  138
were positive  by real-time  PCR.  Clinical  criteria  were  not  sufﬁcient  for distinguishing  between  dengue
and non-dengue  febrile  illness.  The  PCR  reaction  was pre-optimized  using  samples  from  patients  with
known  viral  infection.  It had  similar  sensitivity  compared  to NS1  ELISA  (88%  and  89%, respectively).  We
also  evaluated  three  commercial  lateral  ﬂow  immunochromatographic  tests  for NS1  detection  (BIOEASY,
BIORAD  and  PANBIO).  All  three  tests  showed  high  sensitivity  (94%, 91%  and  81%, respectively)  for  dengue
diagnosis.
Conclusion:  According  to  our  results  it can  be suggested  that  lateral  ﬂow  tests  for NS1  detection  are  the
most  feasible  methods  for earl
Abbreviations: WHO, World Health Organization; DENV, dengue virus; DHF,
engue hemorrhagic fever; BVDV, bovine viral diarrhea virus; PCR, polymerase chain
eaction; PPV, positive predictive value; NPV, negative predictive value; SLEV, Saint
ouis encephalitis virus; YFV, yellow fever virus.
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1. Background
Dengue is a worldly common mosquito-borne disease. Next to
2.5 billion people are at risk of infection in the tropical and sub-
tropical regions [1]. Close to 50 million infections occur globally
every year [2]. Real prevalence of dengue is probably higher as
in less developed countries notiﬁcation is inefﬁcient and diag-
nosis conﬁrmation by laboratory assays is not always available.
Viral transmission occurs most frequently through the bite of Aedes
aegypti and Aedes albopictus mosquitoes. Four viral serotypes were
identiﬁed, DENV-1, DENV-2, DENV-3 and DENV-4 [3]. Dengue clin-
ical features vary from an undifferentiated febrile illness to the
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evere hemorrhagic form (dengue hemorrhagic fever – DHF) that
an lead to shock and death [4,5].
Dengue vector density varies according to rainfall [6]. There-
ore, in Brazil, dengue incidence rises seasonally on summer after
he raining period [7,8]. The incidence also varies signiﬁcantly
mong years in the different regions of the country. From 2009
o 2011, the Department of Health Surveillance of the Ministry
f Health of Brazil reported incidences of 205.5, 530.3 and 400.5
er 100,000 persons, respectively [9]. It is clear that dengue is an
mportant health problem in Brazil. Thus, precise and early diagno-
is is extremely relevant for adequate management of the disease.
engue fever is characterized by unspeciﬁc symptoms and, in most
ases, clinical presentation is similar to other febrile and viral dis-
ases. Thus, clinical criteria are not ideal for the deﬁnitive diagnosis
f dengue [4,10]. There are many diagnostic tools to detect an acute
engue infection, including virus isolation, RT-PCR and real-time
CR, viral genome sequencing, viral antigen detection and serologic
ethods [5,11,12]. In Brazil, serology is a common method used in
ublic health services. RT-PCR and NS1 antigen detection by ELISA
re sensitive methods for early detection of dengue virus infection
13] but they are not widely used in public health services in Brazil.
oreover, during epidemic periods in areas with high incidence
ates, laboratory diagnosis is not always available. In the latter set-
ing, physicians need to rely on clinical and epidemiological criteria
o detect possible dengue cases which can lead to false diagno-
is and failure to detect other viral pathogens with public health
mportance [14]. Recently, lateral ﬂow immunochromatographic
ssays for NS1 antigen detection have been used on primary care
ervices. Those tests are easy to perform, of low comparative cost
hen adopted for mass-surveys, and convenient for distribution to
linical facilities set far away for main healthcare centers in large
ountries, like Brazil. We  aimed to determine their comparative
sefulness in a real clinical epidemic situation.
. Objectives
In the present work, we analyzed the performance of clinical
ata, real-time PCR and serologic tests for NS1 and anti-dengue IgM
n serum samples from consecutive patients in a primary health
are in an endemic area. Belo Horizonte is a large metropolitan
rea with approximately 5 million people in the Southeast region
f Brazil. The aims of the present study were three-fold. Initial
xperiments were carried out to optimize a real-time PCR reaction
gainst serum samples previously subjected to dengue virus isola-
ion. Second, we evaluated the diagnostic performance of clinical
ata and real-time PCR for dengue diagnosis in an actual epidemic
ontext. Third, in known dengue positive samples, we compared
he diagnostic performance of three lateral ﬂow tests for dengue
S1.
. Study design
From January 2010 to March 2010, consecutive patients (at the
ge of 18 or older) with suspected dengue were enrolled in the
tudy after giving written consent to participate. WHO  guidelines
ere used for classifying dengue cases. Clinical data and venous
lood samples were collected on the day of admission (acute sam-
le). Six days after illness onset a second blood sample was  collected
convalescent sample). According to our case deﬁnition, dengue
ositive cases presented NS1 ELISA and/or anti-dengue IgM ELISA
ositive tests. Cases with both NS1 ELISA and anti-dengue IgM
LISA negative tests were considered to have other febrile illness as
ases with indeterminate result in one of the cited test plus negative
esult in the other test. Dengue NS1 Ag kit (Bio-Rad Laboratories)
as used for NS1 detection in acute samples and anti-dengue IgMl Virology 58 (2013) 41– 46
was detected in convalescent samples using MAC-ELISA (PanBio
Diagnostics, Brisbane, Australia).
In order to evaluate the performance of the real-time PCR pro-
tocol we  ﬁrst compared some RNA extraction methods (data not
shown). The most reproducible method was obtained by using the
QIAamp viral RNA mini kit (Qiagen, Hilden, Germany) as reported
before [15]. First-strand cDNA synthesis was  performed using
MMLV  Reverse Transcriptase in standard buffer (Promega, Madi-
son, WI)  and reverse primer 5′GGGTCTCCTCTAACCTCTAGTCCT3′.
Individual real-time PCR reactions were carried out as previously
described by Chien and colleagues [16] in the StepOneTM Real-Time
PCR System (Applied BiosystemsTM). A sensitivity test was per-
formed a priori using known positive samples subjected previously
to dengue virus isolation by inoculation in C6/36 A. albopictus cells.
Dengue virus serotypes were identiﬁed as previously described by
Lanciotti et al. [17] with slight modiﬁcations [16]. The acute sample
obtained from the consecutive patients was  used for evaluating the
performance of the real-time PCR.
Finally, we tested three lateral ﬂow kits for NS1 antigen detec-
tion: Bioeasy – Dengue Eden Test Bioeasy (Standard Diagnosis,
Pajan-dong, Korea), BIORAD – Dengue NS1 AG Strip (Bio-Rad,
Marnes-la-Coquette, France) and PANBIO – Dengue Early Rapid
(Inverness Medical, Sinnamon Park, Australia). We  used acute
samples from consecutive patients presenting positive results in
real-time PCR, NS1 ELISA and anti-dengue IgM ELISA. For the speci-
ﬁcity test we selected negative acute samples. Statistical analysis
was performed in SPSS Statistics 17.0. Categorical and continu-
ous variables where analyzed by Chi-square and Mann–Whitney
respectively. A p value equal or smaller than 0.05 was considered
statistical signiﬁcant. Analysis of sensitivity, speciﬁcity, PPV, NPV
and accuracy were carried out at http://www.openepi.com/.
4. Results
Initial experiments evaluated the sensitivity of the real-time PCR
in 58 serum samples previously subjected to dengue virus isolation
by culture in C6/36 cells. Serotypes were identiﬁed by multiplex
PCR: DENV1 (30 samples), DENV2 (20 samples) and DENV3 (8 sam-
ples). Real-time PCR detected dengue virus in 52 samples (91% of
total). This method also detected DENV4 virus (Fig. 1A).
The speciﬁcity of real-time PCR was  assessed evaluating cul-
ture samples containing other ﬂavivirus (yellow fever virus – YFV-,
bovine viral diarrhea virus – BVDV and Saint Louis encephalitis
virus – SLEV). Real-time PCR melt curves showed an YFV-unrelated
unspeciﬁc curve (possibly primer-dimers) and no ampliﬁcation
products with BVDV samples. The ampliﬁcation products of SLEV
virus samples showed two-peak melting curves, in which one peak
was similar to that detected for dengue samples (Fig. 1B).
Clinical information and samples for RT-PCR and NS1 ELISA were
collected from 181 consecutive patients with suspected dengue on
admission. 124 samples were collected for IgM ELISA at the con-
valescent period from patients that were enrolled in the study on
admission and returned at the convalescent period (6 days of symp-
toms) or patients that were admitted at the convalescent period.
The mean age of subjects was 43 years and 67% were women.
According to the case deﬁnition used in this study, 81% were con-
ﬁrmed dengue cases (146 patients). The frequency of most clinical
and demographic characteristics was  equal in patients with acute
dengue as compared to non-dengue acute illness. Platelets counts
and hematocrit values were similar in both groups (Table 1).Interestingly, subjects with dengue sought medical attention
earlier when compared to non-dengue subjects (3.0 versus 4.2
days). Exanthema was more frequently reported in patients with
dengue. Fever, headache, retro-orbitary pain and myalgia were the
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Fig. 1. Real-time PCR melting curves of positive control ampliﬁcation products (A) and ﬂavivirus samples (B).
Table 1
Epidemiological characteristics of patients enrolled in the study.
Clinical, demographic and laboratorial features Dengue Non-dengue p
Number of patients 146 (80.7%) 35 (19.3%)
Mean  age in years 44 (±16) 42 (±17) 0.332
Gender (M/F) 46 (31%)/100 (69%) 14 (40%)/21 (60%)
Days after illness onset 3.01 4.20 0.014
Platelets counts 136,896 127,818 0.522
Hematocrit 44.31 43.74 0.599
m
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CSecondary dengue (sic) 
Comorbidity (diabetes, asthma, hypertension, gastritis, hypothyroidism) (%) 
Systemic artherial hypertension (%)
ost frequent symptoms among dengue cases but they occurred
qually in both groups (Table 2). 1 patient developed DHF.
DENV1 was the most prevalent serotype corresponding to 57%
f total and 73% of real-time PCR positive samples (Table 3). DENV-4
as found in 4 samples, those are probably the ﬁrst DENV4 reported
ases in Belo Horizonte. DENV4 was ﬁrst detected in Brazil in 1982
18] and recently suggested to be circulating at low levels in the
able 2
orrelation of symptoms presented by patients enrolled in the study.
Symptoms Dengue Non-dengue p
Headache (%) 135 (92.5%) 34 (97.1%) 0.285
Retro-orbitrary pain (%) 114 (78.1%) 27 (77.1%) 0.904
Myalgia (%) 128 (87.7%) 31 (88.6%) 0.574
Arthragia (%) 50 (34.2%) 10 (28.6%) 0.702
Bleeding (%) 19 (13.0%) 2(5.7%) 0.182
Exanthema (%) 56 (38.4%) 7 (20.0%) 0.041
Abdominal pain (%) 32 (21.9%) 9 (25.7%) 0.630
Loss  of appetite (%) 68 (46.6%) 11 (31.4%) 0.105
Diarrhea (%) 41 (28.1%) 12 (34.3%) 0.469
Vomiting (%) 41 (28.1%) 10 (28.6%) 0.954
Dizzness (%) 76 (52.1%) 16 (45.7%) 0.500
Drowsiness (%) 72 (49.3%) 13 (37.1%) 0.195
Confusion (%) 11 (7.5%) 2 (5.7%) 0.523
Difﬁculty breathing (%) 14 (9.6%) 3 (8.6%) 0.576
Cough (%) 30 (20.5%) 11 (31.4%) 0.167
Fatigue (%) 68 (46.6%) 13 (37.1%) 0.31313 (8.9%) 3 (8.6%) 0.626
69 (47.3%) 18 (51.4%) 0.658
60 (41.1%) 15 (42.9%) 0.849
southeast region [19]. Three patients had a mixed DENV-1/DENV-3
infection which evolved as classic dengue fever.
Real-time PCR was positive in 138 samples (Table 4), whereas
94% (129 samples) were positive and 6% (9 samples) were nega-
tive on serological criteria. The primers used in the real-time PCR
were designed from the conserved NS5 coding region of the dengue
virus RNA genome. To assure that the real-time PCR was  detec-
ting dengue virus, we  partially sequenced the genome of one of the
dengue positive samples (GenBank: http://www.ncbi.nlm.nih.gov;
accession: JQ24798; JF917098; JF917097).
Among 124 samples analyzed by IgM capture ELISA, 100 were
positive. 57 patients enrolled on admission (32%) did not show up
Table 3
Correlation of real-time PCR results and dengue serotypes identiﬁed by multiplex
PCR in serum samples from consecutive patients.
Multiplex PCR Realtime PCR Total
Serotype Negative Positive
Negative 40 (93.0%) 4 (2.9%) 44 (24.3%)
DENV1 2 (4.7%) 101 (73.2%) 103 (56.9%
DENV2 0 (0.0%) 8 (5.8%) 8 (4.4%)
DENV3 0 (0.0%) 14 (10.1%) 14 (7.7%)
DENV4 0 (0.0%) 4 (2.9%) 4 (2.2%)
DENV1 and DENV 3 1 (2.3%) 2 (1.4%) 3 (1.7%)
Undeﬁned 0 (0.0%) 5 (3.6%) 5 (2.8%)
Total 43 (100.0%) 138 (100.0%) 181 (100.0%)
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Table 4
Correlation of real-time PCR results with serological diagnosis.
Diagnosis by serological criteria NS1/IgM Total
Non-dengue Dengue
Negative real-time PCR 26 (74.3%) 17 (11.6%) 43 (23.8%)
Positive real-time PCR 9 (25.7%) 129 (88.4%) 138 (76.2%)
Total  35 (100%) 146 (100%) 181 (100%)
Table 5
Correlation of real-time PCR (A) and NS1 ELISA (B) results with diagnosis by all
criteria. Here we considered as positive samples (dengue) those cases presenting
positive real-time PCR and/or NS1 ELISA and/or anti-dengue IgM. Negative samples
(non-dengue) were considered those cases presenting negative real-time PCR and
negative or indeterminate serological tests.
Diagnosis by all criteria (PCR/NS1/IgM) Total
Non-dengue Dengue
Negative NS1 22 (88.0%) 14 (9.0%) 36 (19.9%)
Positive NS1 0 (0%) 137 (87.8%) 137 (75.7%)
Indeterminate 3 (12.0%) 5 (3.2%) 8 (4.4%)
Total 25 (100.0%) 156 (100.0%) 181(100.0%)
Negative PCR 25 (100.0%) 18 (11.5%) 43 (23.8%)
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Table 7
Sensitivity and speciﬁcity of commercial lateral ﬂow tests for dengue NS1 detection
in  serum. A total of 77 samples were selected, 67 specimens were acute samples
taken from patients with positive results in real-time PCR, NS1 ELISA and anti-
dengue IgM ELISA methods and 10 acute samples were taken from patients with
negative results in all tests.
TEST Sensitivity 95% CI Speciﬁcity 95% CI
BIOEASY 63 (94.03%) 85.63–97.65% 10 (100%) 72.25–100%
BIORAD 61 (91.04%) 81.81–95.83% 10 (100%) 72.25–100%
T
S
aPositive PCR 0 (0%) 138 (88.5%) 138 (76.2%)
Total 25 (100.0%) 156 (100.0%) 181(100.0%)
n the convalescent period for second sample collection – thus IgM
LISA was not performed in serum of these patients.
As we found a strong correlation between real-time PCR and
erological diagnosis (p < 0.001) we performed a complementary
nalysis to compare real-time PCR to NS1 ELISA. When we consid-
red as dengue positive cases any test (real-time PCR, NS1 ELISA or
nti-dengue IgM ELISA), NS1 ELISA and real-time PCR sensitivities
ere similar (88% for both; Table 5A and B). NS1 ELISA showed sim-
lar performance compared to real-time PCR particularly regarding
ensitivity and accuracy parameters when we combine methods as
eference tests (Table 6).
We compared three of available commercial NS1 rapid tests.
rom the acute samples of consecutive patients, we  selected 67
pecimens which simultaneously presented positive results for NS1
nd anti-dengue ELISAs and real-time PCR and 10 samples with
egative results for all tests. Table 7 shows that all tests present high
ensitivity (94%, 91% and 81%). One method (BIOEASY) was  simpler
o perform as it did not require additional material besides a sample
ispenser and the test strip. All tests showed 100% speciﬁcity when
e tested negative samples. This is similar to the data given by the
anufacturers.
. Discussion
Few studies have demonstrated the performance of the real-
ime PCR in a real epidemic context. The epidemic situation faced
n the study region from February to May  in 2010 was  one of the
reatest epidemic peaks ever experienced in Belo Horizonte [9].
e addressed early diagnosis tools for dengue analyzing the per-
ormance of real-time PCR, NS1 ELISA and lateral ﬂow tests for
S1 detection. Compared to NS1 ELISA, the real-time PCR showed
able 6
ensitivity, speciﬁcity, positive predictive value (PPV), negative predictive value (NPV) an
lone  or in combination.
Reference test/test NS1/realtime PCR (%) Realtime PCR/NS1 (%)
Sensitivity 88.32 87.68 
Speciﬁcity 61.36 62.79 
PPV  87.68 88.32 
NPV  62.79 61.36 
Diagnostic Accuracy 81.77 81.77 PANBIO 59 (88.06%) 78.17–93.82% 10 (100%) 72.25–100%
similar sensitivity. Lateral ﬂow tests for NS1 detection were the
most feasible methods for dengue early diagnosis as they were
simpler and less expensive than other methods.
As it has been published elsewhere [10,20], it was evident in
our study that symptoms and clinical features were not efﬁcient for
distinguishing dengue and other febrile illness. The only symptom
reported more frequently by patients with conﬁrmed dengue was
exanthema but no more than 38% of patients presented that symp-
tom. Interestingly, patients with dengue sought medical attention
earlier than subjects with other febrile illness. This may be related
to the intensity of pain and discomfort experienced by patients
with dengue, as it is also known as “break bone fever” in Chinese
medicine.
Early diagnosis is important for the clinical management of
dengue and may  prevent unsatisfactory outcomes [11,21–23]. The
performance of methods available for dengue diagnosis varies
according to the disease period. Dengue virus and dengue viral
products are detected in serum at the early illness period, conse-
quently the sensitivity of dengue diagnostics methods as RT-PCR
and real-time PCR, virus isolation or NS1 detection are higher at
ﬁrst days of illness [23]. On the other hand, serologic methods
as anti-dengue IgM have better performance for dengue diagno-
sis at the convalescent phase (around 5–6 days post illness onset)
[23–25], when higher levels of anti-dengue immunoglobulins are
detected in blood. Hence this method presents a disadvantage:
many patients do not return to the point of care for blood collection
because they feel better. Dengue hemorrhagic syndrome manifests
when fever decreases, which occur around that same period, thus
an effective clinical approach would beneﬁt from early diagnosis
[21,23].
The real-time PCR had high sensitivity for dengue diagnosis. It
correlated with serological diagnosis results used in this study for
case deﬁnition (positive NS1 ELISA and/or positive anti-dengue IgM
ELISA) and the overall performance of the method was satisfac-
tory when compared to NS1 ELISA alone and serological methods
d diagnostic accuracy of real-time PCR and NS1 ELISA compared to other methods
 NS1 or IgM/realtime PCR (%) Realtime PCR or IgM/NS1 (%)
88.36 87.58
74.29 89.29
93.48 97.81
60.47 56.82
85.64 87.85
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n combination. Those data are in accordance to previous studies
hat described other real-time PCR protocols [16,26–28].
The real-time PCR used here displayed unspeciﬁc ampliﬁcation
f SLEV sequences, which clearly limits its overall applicability. It
ay  be useful in setting of epidemic situations as the one occur-
ing during the study period. It is interesting to note that other
tudies have used a similar design (i.e. the same or similar pair of
rimers) but have not tested the speciﬁcity against other ﬂavivirus
16,29]. SLEV infection in humans is usually characterized by a sub-
linical or mild febrile illness, although the virus may  also cause
ncephalitis. This is epidemiologically relevant in North America,
here unpredictable epidemics occurred in the last decades [30].
n 2007, an outbreak of SLEV occurred concomitantly with a large
ENV-3 outbreak in the state of São Paulo [14,31,32]. Thus, not
nly plain nucleic acid ampliﬁcation data, but also analysis of the
elting curves of the ampliﬁed products, which displayed different
roﬁles for Dengue and SLEV, should be considered for diagnos-
ic purposes based on real-time PCR, as SLEV mild cases display
ndistinguishable acute febrile illness mimicking dengue fever spe-
ially in the acute phase of infection [14,33]. We  also suggest that
n an uncommon clinical context (for example a suspected case
f viral encephalitis) a speciﬁc qRT-PCR for Saint Louis should be
erformed. Therefore the use of our method should be limited in
atients presenting non usual clinical symptoms. Taking in consid-
ration the complexity of real-time PCR and the particular issue of
peciﬁcity of our method, detection of NS1by lateral ﬂow tests was
ore practicable and very accurate for early diagnosis of dengue.
Commercial kits designs of lateral ﬂow tests vary regarding
ample required (blood, plasma or serum), additional reagents
nd material used. Our data showed that all kits we have tested
resented good sensitivity and speciﬁcity for dengue diagnosis.
owever, the simplest (from the technical point of view) and least
xpensive method (BIOEASY) had higher sensitivity. The latter test
an be performed with blood, plasma and serum samples, it only
equires a sample pipette and no buffer is used. Additionally, it may
e run at bedside using total blood skipping the centrifugation step.
IORAD is designed for NS1 detection in human plasma and serum
nd PANBIO requires serum samples. Therefore, the latter two tests
eed a centrifugation step, additional material and reagents, which
s time and money consuming.
In this study our aim was to perform a comprehensive evalua-
ion of methods for dengue diagnosis in consecutive patients during
n epidemic period. In conclusion, a real-time PCR was optimized
or clinical use, showing good diagnostic performance. No advan-
age of real-time PCR over rapid NS1 detection was evident. Tests
or NS1 have diagnostic performance over 80% in real life detecting
isease (performances of 2 tests were higher than 90%). NS1 should
e used in a real life epidemic setting.
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